Spero Therapeutics, Inc. (SPRO): Weighted Average Diluted Shares
59.04M
Year ended 2025-12-31
+16.2%
3-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 59.04M | +9.3% | 2026-03-26, From 2025-01-01 |
| 2024-12-31 | 54.04M | +2.0% | 2026-03-26, From 2024-01-01 |
| 2023-12-31 | 52.99M | +41.0% | 2025-03-27, From 2023-01-01 |
| 2022-12-31 | 37.59M | +21.7% | 2024-03-13, From 2022-01-01 |
| 2021-12-31 | 30.90M | n/a | 2023-03-30, From 2021-01-01 |